List of Natesto drug patents

Natesto is owned by Acerus.

Natesto contains Testosterone.

Natesto has a total of 5 drug patents out of which 0 drug patents have expired.

Natesto was authorised for market use on 28 May, 2014.

Natesto is available in gel, metered;nasal dosage forms.

Natesto can be used as nasal administration of a testosterone gel to a patient to treat the patient for a condition associated with a deficiency or absence of endogenous testosterone, a method of testosterone replacement therapy comprising the step of nasally administering to a patient in need of such treatment an effective amount of testosterone gel formulation..

The generics of Natesto are possible to be released after 17 March, 2034.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8784882 ACERUS Controlled release delivery system for nasal applications and method of treatment
Feb, 2024

(1 year, 7 days from now)

US8877230 ACERUS Controlled release delivery system for nasal applications
Feb, 2024

(1 year, 7 days from now)

US8574622 ACERUS Controlled release delivery system for nasal applications
Feb, 2024

(1 year, 7 days from now)

US8784869 ACERUS Controlled release delivery system for nasal applications and methods of treatment
Feb, 2024

(1 year, 7 days from now)

US11090312 ACERUS Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
Mar, 2034

(11 years from now)

Drugs and Companies using TESTOSTERONE ingredient

Market Authorisation Date: 28 May, 2014

Treatment: A method of testosterone replacement therapy comprising the step of nasally administering to a patient in need of such treatment an effective amount of testosterone gel formulation.; Nasal administration of a testosterone gel to a patient to treat the patient for a condition associated with a deficiency or absence of endogenous testosterone

Dosage: GEL, METERED;NASAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in